BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinto AR, Maciel LS, Carneiro F, Resende C, Chaves FC, Freitas AF. Systemic nodular panniculitis in a patient with alpha-1 antitrypsin deficiency (PiSS phenotype). Clin Exp Dermatol 1993;18:154-5. [DOI: 10.1111/j.1365-2230.1993.tb01000.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Parr D, Stewart D, Hero I, Stockley R. Panniculitis secondary to extravasation of clarithromycin in a patient with alpha1-antitrypsin deficiency (phenotype PiZ). Br J Dermatol 2003;149:410-3. [DOI: 10.1046/j.1365-2133.2003.05530.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
2 Korver G, Liu C, Petersen M. alpha1-Antitrypsin deficiency presenting with panniculitis and incidental discovery of chronic obstructive pulmonary disease. Int J Dermatol. 2007;46:1078-1080. [PMID: 17910720 DOI: 10.1111/j.1365-4632.2006.03067.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Requena L, Sánchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001;45:325-61; quiz 362-4. [PMID: 11511831 DOI: 10.1067/mjd.2001.114735] [Cited by in Crossref: 332] [Cited by in F6Publishing: 205] [Article Influence: 16.6] [Reference Citation Analysis]
4 Green SL, Gaillard MC, Dewar JB, Ludewick H, Song E, Feldman C. Differences in the prevalence of a TaqI RFLP in the 3' flanking region of the alpha 1-proteinase inhibitor gene between asthmatic and non-asthmatic black and white South Africans. Clin Genet 1997;52:162-6. [PMID: 9377805 DOI: 10.1111/j.1399-0004.1997.tb02537.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
5 Gaillard M, Bothwell J, Dreyer L. A case of systemic nodular panniculitis associated with M1 (Val213) Z phenotype of α1-protease inhibitor. International Journal of Dermatology 1997;36:278-80. [DOI: 10.1111/j.1365-4362.1997.tb03043.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol 2016;174:753-62. [DOI: 10.1111/bjd.14309] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
7 Ortiz PG, Skov BG, Benfeldt E. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options. J Eur Acad Dermatol Venereol. 2005;19:487-490. [PMID: 15987301 DOI: 10.1111/j.1468-3083.2005.01194.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
8 Valverde R, Rosales B, Ortiz-de Frutos FJ, Rodríguez-Peralto JL, Ortiz-Romero PL. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin 2008;26:447-51, vi. [PMID: 18793976 DOI: 10.1016/j.det.2008.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
9 de Oliveira P, Paz-Melgar L, Takahashi MD, Nico MM, Rivitti EA, Mendrone A Jr, Tatsui NH. Alpha-1-antitrypsin deficiency associated with panniculitis treated with plasma exchange therapy. Int J Dermatol. 2004;43:693-697. [PMID: 15357756 DOI: 10.1111/j.1365-4632.2004.02054.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Ricketts JR, Rothe MJ, Grant-Kels JM. Cutaneous simulants of infectious disease. Int J Dermatol 2011;50:1043-57. [PMID: 22126864 DOI: 10.1111/j.1365-4632.2011.04887.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-259. [PMID: 21960536 DOI: 10.1164/rccm.201108-1428CI] [Cited by in Crossref: 253] [Cited by in F6Publishing: 113] [Article Influence: 25.3] [Reference Citation Analysis]
12 Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, Janciauskiene S. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology. 2009;218:370-375. [PMID: 19218787 DOI: 10.1159/000202982] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
13 Chng W, Henderson C. Suppurative panniculitis associated with alpha 1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline. Br J Dermatol 2001;144:1282-3. [DOI: 10.1046/j.1365-2133.2001.04260.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
14 Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236. [PMID: 15978931 DOI: 10.1016/s0140-6736(05)66781-5] [Cited by in Crossref: 386] [Cited by in F6Publishing: 124] [Article Influence: 24.1] [Reference Citation Analysis]
15 Geraminejad P, DeBloom JR 2nd, Walling HW, Sontheimer RD, VanBeek M. Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol. 2004;51:645-655. [PMID: 15389208 DOI: 10.1016/j.jaad.2003.12.053] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]